Vectiopep

CePep AB

This company develops cell-penetrating peptide delivery platforms for nucleic acid based therapeutics and drug discovery applications within the biotechnology and pharmaceutical industries.

Oncocine

The company develops an artificial intelligence platform to design mRNA cancer vaccines for pharmaceutical and biotechnology organisations.

Sensible Biotechnologies

This company develops a cell-based platform to produce mRNA for pharmaceutical firms and biotechnology researchers developing therapeutics and vaccines.

Nuntius Therapeutics

This company develops mRNA and gene-editing therapies using a programmable nanocarrier delivery platform for pharmaceutical companies and research institutions.

Pep-Therapy

This biotechnology company develops intracellular peptide-based targeted therapies to treat patients with advanced solid tumours, including pancreatic and ovarian cancers.

Etherna

This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.

Breeze

This company develops polymer nanoparticles to enable the non-viral delivery of RNA therapeutics to extrahepatic tissues for biotechnology and pharmaceutical organisations.

Gene Therapy Delivery Methods

This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.